Characterization of tumor microenvironment in glioblastoma multiforme identifies ITGB2 as a key immune and stromal related regulator in glial cell types.
Comput Biol Med
2023
165
Enolase represents a metabolic checkpoint controlling the differential exhaustion programmes of hepatitis virus-specific CD8+ T cells.
Gut
2023
72
10
1971-1984
Comprehensive In silico analysis of chaperones identifies CRYAB and P4HA2 as potential therapeutic targets and their small-molecule inhibitors for the treatment of cholangiocarcinoma.
Comput Biol Med
2023
166
A dysfunctional program imprinted by Prostaglandin E2 signaling shuts off NK cell communication pathways and disables immunosurveillance of metastasis
Eur J Immunol
2023
53 Suppl 2
220-220
A distinct stimulatory cDC1 subpopulation amplifies CD8+T cell responses in tumors for protective anticancer immunity
Eur J Immunol
2023
53 Suppl 2
6-6
Prostaglandin E2 curtails interleukin-2-dependent effector expansion from tumor-infiltrating stem-like CD8+T cells to promote cancer immune escape
Eur J Immunol
2023
53 Suppl 2
50-50
Tumor-derived prostaglandin E2 programs cDC1 dysfunction to impair intratumoral orchestration of anti-cancer T cell responses
Eur J Immunol
2023
53 Suppl 2
152-152
Control of cell penetration enhancer shielding and endosomal escape-kinetics crucial for efficient and biocompatible siRNA delivery.
J Control Release
2023
363
101-113
A PKA-associated liver-tissue rheostat curbs T cell receptor signalling and effector function of virus-specific CD8 T cells in chronic viral hepatitis
J Hepatol
2023
78 Suppl 1
S35-S35